TXMD - TherapeuticsMD Inc. (TXMD) CEO Rob Finizio on Q1 2021 Results - Earnings Call Transcript

TherapeuticsMD, Inc. (TXMD) Q1 2021 Earnings Conference Call May 06, 2021, 08:30 AM ET Company Participants Nichol Ochsner - Vice President of Investor Relations Rob Finizio - Chief Executive Officer James D'Arecca - Chief Financial Officer Dawn Halkuff - Chief Commercial Officer Mitchell Krassan - Chief Strategy & Performance Officer Conference Call Participants Dana Flanders - Guggenheim Partners Douglas Tsao - H.C. Wainwright Presentation Operator Good morning, ladies and gentlemen. Thank you for joining us for TherapeuticsMD First Quarter 2021 Financial Results Conference Call. Following prepared remarks from the company, we will open the call for questions. I would now like to turn the call over to TherapeuticsMD's Vice President of Investor Relations, Nichol Ochsner. Nichol? Nichol Ochsner Good morning, everyone. Thank you for joining today to discuss our first quarter financial results and business update. This morning, TherapeuticsMD issued a press release announcing our first quarter financial results. The

For further details see:

TherapeuticsMD, Inc. (TXMD) CEO Rob Finizio on Q1 2021 Results - Earnings Call Transcript